|
WO2020194138A1
|
|
An improved process for the preparation of eliglustat and its intermediate
|
|
US2020185105A1
|
|
Monitoring quality of pharmaceutical manufacturing sites
|
|
WO2020104956A1
|
|
Electrochemical organic reaction setup and methods
|
|
WO2020104930A1
|
|
An improved asymmetric synthesis of azaspiro compounds
|
|
WO2020039324A1
|
|
An improved led based photochemical reactor
|
|
WO2020012403A1
|
|
An improved process for diaster-eoselective synthesis of vicinal diamines
|
|
WO2019202522A1
|
|
An improved asymmetric synthesis of alpha-branched chiral amines
|
|
US2021061752A1
|
|
AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-(DIARYLMETHYL) ALKYL AMINES
|
|
EP3762371A1
|
|
An improved process for the preparation of vortioxetine and salts thereof
|
|
US2020354308A1
|
|
An improved process for the preparation of droxidopa and its intermediate
|
|
WO2019073427A1
|
|
A process for the preparation of trientine dihydrochloride
|
|
WO2019073431A1
|
|
An improved process for the preparation of apremilast and its intermediate
|
|
US2020123186A1
|
|
A process for the preparation of sglt2 inhibitors and intermediates thereof
|
|
US2018230116A1
|
|
Process for the preparation of vortioxetine and salts thereof
|
|
CA3048968A1
|
|
Oral pharmaceutical composition of lurasidone and preparation thereof
|
|
EP3436426A1
|
|
An improved process for the preparation of droxidopa and its intermediate
|
|
US2018354977A1
|
|
Process for preparation of fosaprepitant dimeglumine and an intermediate thereof
|
|
WO2017093890A1
|
|
Clobazam tablet formulation and process for its preparation
|
|
ZA201606656B
|
|
Ror-gamma modulators and uses thereof
|
|
WO2017037662A1
|
|
An improved process for the preparation of paroxetine and its intermediate
|
